Teva Pharmaceutical (Israel) Probability of Future Stock Price Finishing Over 5929.0
| TEVA Stock | ILA 5,977 64.00 1.06% |
Teva |
Teva Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Teva Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Teva Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Teva Pharmaceutical generated a negative expected return over the last 90 days | |
| The company reported the revenue of 14.93 B. Net Loss for the year was (2.35 B) with profit before overhead, payroll, taxes, and interest of 6.97 B. |
Teva Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Teva Stock often depends not only on the future outlook of the current and potential Teva Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Teva Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 B |
Teva Pharmaceutical Technical Analysis
Teva Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Teva Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Teva Pharmaceutical Industries. In general, you should focus on analyzing Teva Stock price patterns and their correlations with different microeconomic environments and drivers.
Teva Pharmaceutical Predictive Forecast Models
Teva Pharmaceutical's time-series forecasting models is one of many Teva Pharmaceutical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Teva Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Teva Pharmaceutical
Checking the ongoing alerts about Teva Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Teva Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Teva Pharmaceutical generated a negative expected return over the last 90 days | |
| The company reported the revenue of 14.93 B. Net Loss for the year was (2.35 B) with profit before overhead, payroll, taxes, and interest of 6.97 B. |
Other Information on Investing in Teva Stock
Teva Pharmaceutical financial ratios help investors to determine whether Teva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teva with respect to the benefits of owning Teva Pharmaceutical security.